Menu

Filtros : "FCF" "University of Alberta (UAlberta)" Removido: " IQ012" Limpar

Filtros

Refine with date range

1 - 20 (23 records)

  • Artigo de periodico

    Update on gastrointestinal biorelevant media and physiologically relevant dissolution conditions (2022)

    Silva, Daniela Amaral ; Davies, Neal M; Bou-Chacra, Nadia Araci ; Ferraz, Humberto Gomes ; Löbenberg, Raimar

    Source: Dissolution Technologies. Unidade: FCF

    Subjects: TRATO GASTROINTESTINAL, FARMACOCINÉTICA, MEDICAMENTO

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      SILVA, Daniela Amaral et al. Update on gastrointestinal biorelevant media and physiologically relevant dissolution conditions. Dissolution Technologies, v. 29, n. 2, p. 62-75, 2022Tradução . . Disponível em: https://doi.org/10.14227/DT290222P62. Acesso em: 02 maio 2024.

    • APA

      Silva, D. A., Davies, N. M., Bou-Chacra, N. A., Ferraz, H. G., & Löbenberg, R. (2022). Update on gastrointestinal biorelevant media and physiologically relevant dissolution conditions. Dissolution Technologies, 29( 2), 62-75. doi:10.14227/DT290222P62

    • NLM

      Silva DA, Davies NM, Bou-Chacra NA, Ferraz HG, Löbenberg R. Update on gastrointestinal biorelevant media and physiologically relevant dissolution conditions [Internet]. Dissolution Technologies. 2022 ; 29( 2): 62-75.[citado 2024 maio 02 ] Available from: https://doi.org/10.14227/DT290222P62

    • Vancouver

      Silva DA, Davies NM, Bou-Chacra NA, Ferraz HG, Löbenberg R. Update on gastrointestinal biorelevant media and physiologically relevant dissolution conditions [Internet]. Dissolution Technologies. 2022 ; 29( 2): 62-75.[citado 2024 maio 02 ] Available from: https://doi.org/10.14227/DT290222P62

  • Artigo de periodico

    Toward global standards for comparator pharmaceutical products: case studies of amoxicillin, metronidazole, and zidovudine in the americas (2012)

    Löbenberg, Raimar; Bou-Chacra, Nadia Araci ; Stippler, Erika S; Shah, Vinod P; De Stefano, Anthony J; Hauck, Walter W; Williams, Roger L

    Source: American Association of Pharmaceutical Scientists. Unidade: FCF

    Assunto: BIOEQUIVALÊNCIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      LÖBENBERG, Raimar et al. Toward global standards for comparator pharmaceutical products: case studies of amoxicillin, metronidazole, and zidovudine in the americas. American Association of Pharmaceutical Scientists, v. 14, n. 3, p. 462-472, 2012Tradução . . Disponível em: https://doi.org/10.1208/s12248-012-9350-9. Acesso em: 02 maio 2024.

    • APA

      Löbenberg, R., Bou-Chacra, N. A., Stippler, E. S., Shah, V. P., De Stefano, A. J., Hauck, W. W., & Williams, R. L. (2012). Toward global standards for comparator pharmaceutical products: case studies of amoxicillin, metronidazole, and zidovudine in the americas. American Association of Pharmaceutical Scientists, 14( 3), 462-472. doi:10.1208/s12248-012-9350-9

    • NLM

      Löbenberg R, Bou-Chacra NA, Stippler ES, Shah VP, De Stefano AJ, Hauck WW, Williams RL. Toward global standards for comparator pharmaceutical products: case studies of amoxicillin, metronidazole, and zidovudine in the americas [Internet]. American Association of Pharmaceutical Scientists. 2012 ; 14( 3): 462-472.[citado 2024 maio 02 ] Available from: https://doi.org/10.1208/s12248-012-9350-9

    • Vancouver

      Löbenberg R, Bou-Chacra NA, Stippler ES, Shah VP, De Stefano AJ, Hauck WW, Williams RL. Toward global standards for comparator pharmaceutical products: case studies of amoxicillin, metronidazole, and zidovudine in the americas [Internet]. American Association of Pharmaceutical Scientists. 2012 ; 14( 3): 462-472.[citado 2024 maio 02 ] Available from: https://doi.org/10.1208/s12248-012-9350-9

  • Artigo de periodico

    The critical role of NIR spectroscopy and statistical process control (SPC) strategy towards captopril tablets (25 mg) manufacturing process understanding: a case study (2015)

    Curtivo, Cátia Panizzon Dal; Funghi, Nathália Bitencourt; Tavares, Guilherme Diniz; Barbosa, Sávio Fujita; Löbenberg, Raimar; Bou-Chacra, Nadia Araci

    Source: Pharmaceutical Development and Technology. Unidade: FCF

    Subjects: ESPECTROSCOPIA INFRAVERMELHA, ANÁLISE MULTIVARIADA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      CURTIVO, Cátia Panizzon Dal et al. The critical role of NIR spectroscopy and statistical process control (SPC) strategy towards captopril tablets (25 mg) manufacturing process understanding: a case study. Pharmaceutical Development and Technology, v. 20, n. 3, p. 345-351, 2015Tradução . . Disponível em: https://doi.org/10.3109/10837450.2013.867448. Acesso em: 02 maio 2024.

    • APA

      Curtivo, C. P. D., Funghi, N. B., Tavares, G. D., Barbosa, S. F., Löbenberg, R., & Bou-Chacra, N. A. (2015). The critical role of NIR spectroscopy and statistical process control (SPC) strategy towards captopril tablets (25 mg) manufacturing process understanding: a case study. Pharmaceutical Development and Technology, 20( 3), 345-351. doi:10.3109/10837450.2013.867448

    • NLM

      Curtivo CPD, Funghi NB, Tavares GD, Barbosa SF, Löbenberg R, Bou-Chacra NA. The critical role of NIR spectroscopy and statistical process control (SPC) strategy towards captopril tablets (25 mg) manufacturing process understanding: a case study [Internet]. Pharmaceutical Development and Technology. 2015 ; 20( 3): 345-351.[citado 2024 maio 02 ] Available from: https://doi.org/10.3109/10837450.2013.867448

    • Vancouver

      Curtivo CPD, Funghi NB, Tavares GD, Barbosa SF, Löbenberg R, Bou-Chacra NA. The critical role of NIR spectroscopy and statistical process control (SPC) strategy towards captopril tablets (25 mg) manufacturing process understanding: a case study [Internet]. Pharmaceutical Development and Technology. 2015 ; 20( 3): 345-351.[citado 2024 maio 02 ] Available from: https://doi.org/10.3109/10837450.2013.867448

  • Artigo de periodico

    Statistical evaluation of tablet coating processes: influence of pan design and solvent type (2010)

    Melo Junior, Valdomero Pereira de; Löbenberg, Raimar; Bou-Chacra, Nadia Araci

    Source: Brazilian Journal of Pharmaceutical Sciences. Unidade: FCF

    Assunto: COMPRIMIDOS (REVESTIMENTOS)

    Acesso à fonteAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      MELO JUNIOR, Valdomero Pereira de e LÖBENBERG, Raimar e BOU-CHACRA, Nadia Araci. Statistical evaluation of tablet coating processes: influence of pan design and solvent type. Brazilian Journal of Pharmaceutical Sciences, v. 46, n. 4, p. 657-664, 2010Tradução . . Disponível em: https://doi.org/10.1590/s1984-82502010000400007. Acesso em: 02 maio 2024.

    • APA

      Melo Junior, V. P. de, Löbenberg, R., & Bou-Chacra, N. A. (2010). Statistical evaluation of tablet coating processes: influence of pan design and solvent type. Brazilian Journal of Pharmaceutical Sciences, 46( 4), 657-664. doi:10.1590/s1984-82502010000400007

    • NLM

      Melo Junior VP de, Löbenberg R, Bou-Chacra NA. Statistical evaluation of tablet coating processes: influence of pan design and solvent type [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2010 ; 46( 4): 657-664.[citado 2024 maio 02 ] Available from: https://doi.org/10.1590/s1984-82502010000400007

    • Vancouver

      Melo Junior VP de, Löbenberg R, Bou-Chacra NA. Statistical evaluation of tablet coating processes: influence of pan design and solvent type [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2010 ; 46( 4): 657-664.[citado 2024 maio 02 ] Available from: https://doi.org/10.1590/s1984-82502010000400007

  • Artigo de periodico

    Reverse phase high-performance liquid chromatography for quantification of hydroxymethylnitrofurazone in polymeric nanoparticles (2015)

    Monteiro, Lis Marrie; Tavares, Guilherme Diniz; Ferreira, Elizabeth Igne ; Consiglieri, Vladi Olga ; Bou-Chacra, Nadia Araci ; Löbenberg, Raimar

    Source: Brazilian Journal of Pharmaceutical Sciences. Unidade: FCF

    Subjects: CROMATOGRAFIA LÍQUIDA DE ALTA EFICIÊNCIA, NANOPARTÍCULAS

    Acesso à fonteAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      MONTEIRO, Lis Marrie et al. Reverse phase high-performance liquid chromatography for quantification of hydroxymethylnitrofurazone in polymeric nanoparticles. Brazilian Journal of Pharmaceutical Sciences, v. 51, n. 3, p. 561-567, 2015Tradução . . Disponível em: https://doi.org/10.1590/s1984-82502015000300008. Acesso em: 02 maio 2024.

    • APA

      Monteiro, L. M., Tavares, G. D., Ferreira, E. I., Consiglieri, V. O., Bou-Chacra, N. A., & Löbenberg, R. (2015). Reverse phase high-performance liquid chromatography for quantification of hydroxymethylnitrofurazone in polymeric nanoparticles. Brazilian Journal of Pharmaceutical Sciences, 51( 3), 561-567. doi:10.1590/s1984-82502015000300008

    • NLM

      Monteiro LM, Tavares GD, Ferreira EI, Consiglieri VO, Bou-Chacra NA, Löbenberg R. Reverse phase high-performance liquid chromatography for quantification of hydroxymethylnitrofurazone in polymeric nanoparticles [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2015 ; 51( 3): 561-567.[citado 2024 maio 02 ] Available from: https://doi.org/10.1590/s1984-82502015000300008

    • Vancouver

      Monteiro LM, Tavares GD, Ferreira EI, Consiglieri VO, Bou-Chacra NA, Löbenberg R. Reverse phase high-performance liquid chromatography for quantification of hydroxymethylnitrofurazone in polymeric nanoparticles [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2015 ; 51( 3): 561-567.[citado 2024 maio 02 ] Available from: https://doi.org/10.1590/s1984-82502015000300008

  • Artigo de periodico

    Provisional biopharmaceutical classification of some common herbs used in western medicine (2012)

    Waldmann, Sarah; Almukainzi, May; Bou-Chacra, Nadia Araci ; Amidon, Gordon L; Beom-Jin, Lee; Feng, Jianfang; Kanfer, Isadore; Zuo, Joan Zhong; Wei, Hai; Bolger, Michael B; Löbenberg, Raimar

    Source: Molecular Pharmaceutics. Unidade: FCF

    Subjects: EXTRATOS (FORMAS FARMACÊUTICAS), PLANTAS HERBÁCEAS, SOLUBILIDADE

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      WALDMANN, Sarah et al. Provisional biopharmaceutical classification of some common herbs used in western medicine. Molecular Pharmaceutics, v. 9, n. 4, p. 815-822, 2012Tradução . . Disponível em: https://doi.org/10.1021/mp200162b. Acesso em: 02 maio 2024.

    • APA

      Waldmann, S., Almukainzi, M., Bou-Chacra, N. A., Amidon, G. L., Beom-Jin, L., Feng, J., et al. (2012). Provisional biopharmaceutical classification of some common herbs used in western medicine. Molecular Pharmaceutics, 9( 4), 815-822. doi:10.1021/mp200162b

    • NLM

      Waldmann S, Almukainzi M, Bou-Chacra NA, Amidon GL, Beom-Jin L, Feng J, Kanfer I, Zuo JZ, Wei H, Bolger MB, Löbenberg R. Provisional biopharmaceutical classification of some common herbs used in western medicine [Internet]. Molecular Pharmaceutics. 2012 ; 9( 4): 815-822.[citado 2024 maio 02 ] Available from: https://doi.org/10.1021/mp200162b

    • Vancouver

      Waldmann S, Almukainzi M, Bou-Chacra NA, Amidon GL, Beom-Jin L, Feng J, Kanfer I, Zuo JZ, Wei H, Bolger MB, Löbenberg R. Provisional biopharmaceutical classification of some common herbs used in western medicine [Internet]. Molecular Pharmaceutics. 2012 ; 9( 4): 815-822.[citado 2024 maio 02 ] Available from: https://doi.org/10.1021/mp200162b

  • Artigo de periodico

    Promising nanotherapy in treating leishmaniasis (2018)

    Souza, Aline de; Marins, Débora Soares Souza; Mathias, Samir Leite; Monteiro, Lis Marie; Yukuyama, Megumi Nishitani; Scarim, Cauê Benito; Löbenberg, Raimar; Bou-Chacra, Nadia Araci

    Source: International Journal of Pharmaceutics. Unidade: FCF

    Subjects: LEISHMANIA, NANOTECNOLOGIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      SOUZA, Aline de et al. Promising nanotherapy in treating leishmaniasis. International Journal of Pharmaceutics, v. 547, n. 1-2, p. 421-431, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.ijpharm.2018.06.018. Acesso em: 02 maio 2024.

    • APA

      Souza, A. de, Marins, D. S. S., Mathias, S. L., Monteiro, L. M., Yukuyama, M. N., Scarim, C. B., et al. (2018). Promising nanotherapy in treating leishmaniasis. International Journal of Pharmaceutics, 547( 1-2), 421-431. doi:10.1016/j.ijpharm.2018.06.018

    • NLM

      Souza A de, Marins DSS, Mathias SL, Monteiro LM, Yukuyama MN, Scarim CB, Löbenberg R, Bou-Chacra NA. Promising nanotherapy in treating leishmaniasis [Internet]. International Journal of Pharmaceutics. 2018 ; 547( 1-2): 421-431.[citado 2024 maio 02 ] Available from: https://doi.org/10.1016/j.ijpharm.2018.06.018

    • Vancouver

      Souza A de, Marins DSS, Mathias SL, Monteiro LM, Yukuyama MN, Scarim CB, Löbenberg R, Bou-Chacra NA. Promising nanotherapy in treating leishmaniasis [Internet]. International Journal of Pharmaceutics. 2018 ; 547( 1-2): 421-431.[citado 2024 maio 02 ] Available from: https://doi.org/10.1016/j.ijpharm.2018.06.018

  • Trabalho de evento-resumo periodico

    Orotic acid nanocrystals: preparation and physical-chemical caracterization (2014)

    Compri, Jéssica de Cássia Zaghi; Felli, Veni Maria Andres; Barbosa, Savio Fujita; Morales, Ivan Andrés Cordova; Araujo, Gabriel Lima Barros de ; Takatsuka, Takayuki; Loebenberg, Raimar; Bou-Chacra, Nadia Araci

    Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Pharmaceutical Science and Technology Meeting of the Faculty of Pharmaceutical Sciences. Unidade: FCF

    Assunto: NANOTECNOLOGIA

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      COMPRI, Jéssica de Cássia Zaghi et al. Orotic acid nanocrystals: preparation and physical-chemical caracterization. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 02 maio 2024. , 2014

    • APA

      Compri, J. de C. Z., Felli, V. M. A., Barbosa, S. F., Morales, I. A. C., Araujo, G. L. B. de, Takatsuka, T., et al. (2014). Orotic acid nanocrystals: preparation and physical-chemical caracterization. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.

    • NLM

      Compri J de CZ, Felli VMA, Barbosa SF, Morales IAC, Araujo GLB de, Takatsuka T, Loebenberg R, Bou-Chacra NA. Orotic acid nanocrystals: preparation and physical-chemical caracterization. Brazilian Journal of Pharmaceutical Sciences. 2014 ; 50 30 res. FCF056.[citado 2024 maio 02 ]

    • Vancouver

      Compri J de CZ, Felli VMA, Barbosa SF, Morales IAC, Araujo GLB de, Takatsuka T, Loebenberg R, Bou-Chacra NA. Orotic acid nanocrystals: preparation and physical-chemical caracterization. Brazilian Journal of Pharmaceutical Sciences. 2014 ; 50 30 res. FCF056.[citado 2024 maio 02 ]

  • Artigo de periodico

    Oral administration of buparvaquone nanostructured lipid carrier enables in vivo activity against Leishmania infantum (2022)

    Monteiro, Lis Marie ; Löbenberg, Raimar ; Barbosa, Eduardo José ; Araujo, Gabriel Lima Barros de ; Sato, Paula Keiko ; Kanashiro, Edite Hatsumi Yamashiro ; Eliodoro, Raissa Heloisa de Araujo; Rocha, Mussya; Freitas, Vera Lucia Teixeira de ; Fotaki, Nikoletta; Bou-Chacra, Nadia Araci

    Source: European Journal of Pharmaceutical Sciences. Unidades: FCF, IMT, FM

    Subjects: LIPÍDEOS, LEISHMANIOSE VISCERAL, DOENÇAS NEGLIGENCIADAS, NANOTECNOLOGIA

    Versão PublicadaAcesso à fonteAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      MONTEIRO, Lis Marie et al. Oral administration of buparvaquone nanostructured lipid carrier enables in vivo activity against Leishmania infantum. European Journal of Pharmaceutical Sciences, v. 169, p. 1-11 art. 106097, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.ejps.2021.106097. Acesso em: 02 maio 2024.

    • APA

      Monteiro, L. M., Löbenberg, R., Barbosa, E. J., Araujo, G. L. B. de, Sato, P. K., Kanashiro, E. H. Y., et al. (2022). Oral administration of buparvaquone nanostructured lipid carrier enables in vivo activity against Leishmania infantum. European Journal of Pharmaceutical Sciences, 169, 1-11 art. 106097. doi:10.1016/j.ejps.2021.106097

    • NLM

      Monteiro LM, Löbenberg R, Barbosa EJ, Araujo GLB de, Sato PK, Kanashiro EHY, Eliodoro RH de A, Rocha M, Freitas VLT de, Fotaki N, Bou-Chacra NA. Oral administration of buparvaquone nanostructured lipid carrier enables in vivo activity against Leishmania infantum [Internet]. European Journal of Pharmaceutical Sciences. 2022 ; 169 1-11 art. 106097.[citado 2024 maio 02 ] Available from: https://doi.org/10.1016/j.ejps.2021.106097

    • Vancouver

      Monteiro LM, Löbenberg R, Barbosa EJ, Araujo GLB de, Sato PK, Kanashiro EHY, Eliodoro RH de A, Rocha M, Freitas VLT de, Fotaki N, Bou-Chacra NA. Oral administration of buparvaquone nanostructured lipid carrier enables in vivo activity against Leishmania infantum [Internet]. European Journal of Pharmaceutical Sciences. 2022 ; 169 1-11 art. 106097.[citado 2024 maio 02 ] Available from: https://doi.org/10.1016/j.ejps.2021.106097

  • Artigo de periodico

    Investigation of the performance of the disintegration test for dietary supplements (2010)

    Almukainz, May; Salehi, Mahnor; Bou-Chacra, Nadia Araci ; Löbenberg, Raimar

    Source: American Association of Pharmaceutical Scientists Journal. Unidade: FCF

    Subjects: SUPLEMENTOS DIETÉTICOS, COMPRIMIDOS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      ALMUKAINZ, May et al. Investigation of the performance of the disintegration test for dietary supplements. American Association of Pharmaceutical Scientists Journal, v. 12, n. 4, p. 602-607, 2010Tradução . . Disponível em: https://doi.org/10.1208/s12248-010-9221-1. Acesso em: 02 maio 2024.

    • APA

      Almukainz, M., Salehi, M., Bou-Chacra, N. A., & Löbenberg, R. (2010). Investigation of the performance of the disintegration test for dietary supplements. American Association of Pharmaceutical Scientists Journal, 12( 4), 602-607. doi:10.1208/s12248-010-9221-1

    • NLM

      Almukainz M, Salehi M, Bou-Chacra NA, Löbenberg R. Investigation of the performance of the disintegration test for dietary supplements [Internet]. American Association of Pharmaceutical Scientists Journal. 2010 ; 12( 4): 602-607.[citado 2024 maio 02 ] Available from: https://doi.org/10.1208/s12248-010-9221-1

    • Vancouver

      Almukainz M, Salehi M, Bou-Chacra NA, Löbenberg R. Investigation of the performance of the disintegration test for dietary supplements [Internet]. American Association of Pharmaceutical Scientists Journal. 2010 ; 12( 4): 602-607.[citado 2024 maio 02 ] Available from: https://doi.org/10.1208/s12248-010-9221-1

  • Trabalho de evento-resumo periodico

    Intrinsic dissolution simulations using 'DDDPlus POT. TM' as a tool for early BCS classification (2016)

    Duque, Marcelo Dutra; Issa, Michele Georges; Silva, Daniela Amaral; Kakuda, Beatriz Ayumi Sakamoto; Rodrigues, Leticia Norma Carpentieri; Löbenberg, Raimar; Ferraz, Humberto Gomes

    Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Pharmaceutical Sciences and Technology Meeting of the Faculty of Pharmaceutical Sciences, University of São Paulo. Unidade: FCF

    Assunto: FÁRMACOS

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      DUQUE, Marcelo Dutra et al. Intrinsic dissolution simulations using 'DDDPlus POT. TM' as a tool for early BCS classification. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 02 maio 2024. , 2016

    • APA

      Duque, M. D., Issa, M. G., Silva, D. A., Kakuda, B. A. S., Rodrigues, L. N. C., Löbenberg, R., & Ferraz, H. G. (2016). Intrinsic dissolution simulations using 'DDDPlus POT. TM' as a tool for early BCS classification. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.

    • NLM

      Duque MD, Issa MG, Silva DA, Kakuda BAS, Rodrigues LNC, Löbenberg R, Ferraz HG. Intrinsic dissolution simulations using 'DDDPlus POT. TM' as a tool for early BCS classification. Brazilian Journal of Pharmaceutical Sciences. 2016 ; 52 32 res. FCF060.[citado 2024 maio 02 ]

    • Vancouver

      Duque MD, Issa MG, Silva DA, Kakuda BAS, Rodrigues LNC, Löbenberg R, Ferraz HG. Intrinsic dissolution simulations using 'DDDPlus POT. TM' as a tool for early BCS classification. Brazilian Journal of Pharmaceutical Sciences. 2016 ; 52 32 res. FCF060.[citado 2024 maio 02 ]

  • Trabalho de evento

    In-vitro model to forecast the lymphatic uptake/inhibition of drugs via chylomicrons (2022)

    Yousef, Malaz ; Bou-Chacra, Nadia Araci ; Davies, Neal M; Löbenberg, Raimar

    Source: Abstracts. Conference titles: Research Day Equity in Health and Research. Unidade: FCF

    Subjects: FÁRMACOS, XENOBIÓTICO

    Acesso à fonteHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      YOUSEF, Malaz et al. In-vitro model to forecast the lymphatic uptake/inhibition of drugs via chylomicrons. 2022, Anais.. Alberta: University of Alberta, 2022. Disponível em: https://www.cspscanada.org/wp-content/uploads/CSPS-2022-Malaz-Yousef.pdf. Acesso em: 02 maio 2024.

    • APA

      Yousef, M., Bou-Chacra, N. A., Davies, N. M., & Löbenberg, R. (2022). In-vitro model to forecast the lymphatic uptake/inhibition of drugs via chylomicrons. In Abstracts. Alberta: University of Alberta. Recuperado de https://www.cspscanada.org/wp-content/uploads/CSPS-2022-Malaz-Yousef.pdf

    • NLM

      Yousef M, Bou-Chacra NA, Davies NM, Löbenberg R. In-vitro model to forecast the lymphatic uptake/inhibition of drugs via chylomicrons [Internet]. Abstracts. 2022 ;[citado 2024 maio 02 ] Available from: https://www.cspscanada.org/wp-content/uploads/CSPS-2022-Malaz-Yousef.pdf

    • Vancouver

      Yousef M, Bou-Chacra NA, Davies NM, Löbenberg R. In-vitro model to forecast the lymphatic uptake/inhibition of drugs via chylomicrons [Internet]. Abstracts. 2022 ;[citado 2024 maio 02 ] Available from: https://www.cspscanada.org/wp-content/uploads/CSPS-2022-Malaz-Yousef.pdf

  • Trabalho de evento

    In vitro study of a foamable microemulsion for improved topical delivery of diclofenac sodium (2022)

    Hajjar, Braa; Zuo, Jieyu ; Azami, Shirzad; Silva, Daniela Amaral ; Bou-Chacra, Nadia Araci ; Löbenberg, Raimar

    Source: Abstracts. Conference titles: Research Day Equity in Health and Research. Unidade: FCF

    Assunto: FÁRMACOS

    Acesso à fonteHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      HAJJAR, Braa et al. In vitro study of a foamable microemulsion for improved topical delivery of diclofenac sodium. 2022, Anais.. Alberta: University of Alberta, 2022. Disponível em: https://www.cspscanada.org/wp-content/uploads/CSPS-2022-Zuo-poster.pdf. Acesso em: 02 maio 2024.

    • APA

      Hajjar, B., Zuo, J., Azami, S., Silva, D. A., Bou-Chacra, N. A., & Löbenberg, R. (2022). In vitro study of a foamable microemulsion for improved topical delivery of diclofenac sodium. In Abstracts. Alberta: University of Alberta. Recuperado de https://www.cspscanada.org/wp-content/uploads/CSPS-2022-Zuo-poster.pdf

    • NLM

      Hajjar B, Zuo J, Azami S, Silva DA, Bou-Chacra NA, Löbenberg R. In vitro study of a foamable microemulsion for improved topical delivery of diclofenac sodium [Internet]. Abstracts. 2022 ;[citado 2024 maio 02 ] Available from: https://www.cspscanada.org/wp-content/uploads/CSPS-2022-Zuo-poster.pdf

    • Vancouver

      Hajjar B, Zuo J, Azami S, Silva DA, Bou-Chacra NA, Löbenberg R. In vitro study of a foamable microemulsion for improved topical delivery of diclofenac sodium [Internet]. Abstracts. 2022 ;[citado 2024 maio 02 ] Available from: https://www.cspscanada.org/wp-content/uploads/CSPS-2022-Zuo-poster.pdf

  • Artigo de periodico

    In vitro release kinetics of antituberculosis drugs from nanoparticles assessed using a modified dissolution apparatus (2013)

    Gao, Yuan; Zuo, Jieyu; Bou-Chacra, Nadia Araci ; Pinto, Terezinha de Jesus Andreoli ; Clas, Sophie Dorothee; Walker, Roderick B; Löbenberg, Raimar

    Source: BioMed Research International. Unidade: FCF

    Subjects: NANOPARTÍCULAS, ANTI-INFECCIOSOS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      GAO, Yuan et al. In vitro release kinetics of antituberculosis drugs from nanoparticles assessed using a modified dissolution apparatus. BioMed Research International, p. 1-9 art. 136590, 2013Tradução . . Disponível em: https://doi.org/10.1155/2013/136590. Acesso em: 02 maio 2024.

    • APA

      Gao, Y., Zuo, J., Bou-Chacra, N. A., Pinto, T. de J. A., Clas, S. D., Walker, R. B., & Löbenberg, R. (2013). In vitro release kinetics of antituberculosis drugs from nanoparticles assessed using a modified dissolution apparatus. BioMed Research International, 1-9 art. 136590. doi:10.1155/2013/136590

    • NLM

      Gao Y, Zuo J, Bou-Chacra NA, Pinto T de JA, Clas SD, Walker RB, Löbenberg R. In vitro release kinetics of antituberculosis drugs from nanoparticles assessed using a modified dissolution apparatus [Internet]. BioMed Research International. 2013 ; 1-9 art. 136590.[citado 2024 maio 02 ] Available from: https://doi.org/10.1155/2013/136590

    • Vancouver

      Gao Y, Zuo J, Bou-Chacra NA, Pinto T de JA, Clas SD, Walker RB, Löbenberg R. In vitro release kinetics of antituberculosis drugs from nanoparticles assessed using a modified dissolution apparatus [Internet]. BioMed Research International. 2013 ; 1-9 art. 136590.[citado 2024 maio 02 ] Available from: https://doi.org/10.1155/2013/136590

  • Artigo de periodico

    Highly water-soluble orotic acid nanocrystals produced by high-energy milling (2019)

    Compri, Jéssica de Cássia Zaghi; Felli, Veni Maria Andres; Lourenço, Felipe Rebello ; Takatsuka, Takayuki; Fotaki, Nikoletta; Löbenberg, Raimar; Bou-Chacra, Nadia Araci ; Araujo, Gabriel Lima Barros de

    Source: Journal of Pharmaceutical Sciences. Unidade: FCF

    Subjects: COMPOSTOS HETEROCÍCLICOS, SOLUBILIDADE

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      COMPRI, Jéssica de Cássia Zaghi et al. Highly water-soluble orotic acid nanocrystals produced by high-energy milling. Journal of Pharmaceutical Sciences, v. 108, n. 5, p. 1848-1856, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.xphs.2018.12.015. Acesso em: 02 maio 2024.

    • APA

      Compri, J. de C. Z., Felli, V. M. A., Lourenço, F. R., Takatsuka, T., Fotaki, N., Löbenberg, R., et al. (2019). Highly water-soluble orotic acid nanocrystals produced by high-energy milling. Journal of Pharmaceutical Sciences, 108( 5), 1848-1856. doi:10.1016/j.xphs.2018.12.015

    • NLM

      Compri J de CZ, Felli VMA, Lourenço FR, Takatsuka T, Fotaki N, Löbenberg R, Bou-Chacra NA, Araujo GLB de. Highly water-soluble orotic acid nanocrystals produced by high-energy milling [Internet]. Journal of Pharmaceutical Sciences. 2019 ; 108( 5): 1848-1856.[citado 2024 maio 02 ] Available from: https://doi.org/10.1016/j.xphs.2018.12.015

    • Vancouver

      Compri J de CZ, Felli VMA, Lourenço FR, Takatsuka T, Fotaki N, Löbenberg R, Bou-Chacra NA, Araujo GLB de. Highly water-soluble orotic acid nanocrystals produced by high-energy milling [Internet]. Journal of Pharmaceutical Sciences. 2019 ; 108( 5): 1848-1856.[citado 2024 maio 02 ] Available from: https://doi.org/10.1016/j.xphs.2018.12.015

  • Artigo de periodico

    Evaluation of the rupture test for stability studies of soft-shell capsules (2017)

    Bachour, Ghada; Bou-Chacra, Nadia Araci ; Löbenberg, Raimar

    Source: Dissolution Technologies. Unidade: FCF

    Subjects: CÁPSULAS, RUPTURA DOS MATERIAIS, TESTES ENZIMÁTICOS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      BACHOUR, Ghada e BOU-CHACRA, Nadia Araci e LÖBENBERG, Raimar. Evaluation of the rupture test for stability studies of soft-shell capsules. Dissolution Technologies, v. 24, n. 2, p. 16-19, 2017Tradução . . Disponível em: https://doi.org/10.14227/DT240217P16. Acesso em: 02 maio 2024.

    • APA

      Bachour, G., Bou-Chacra, N. A., & Löbenberg, R. (2017). Evaluation of the rupture test for stability studies of soft-shell capsules. Dissolution Technologies, 24( 2), 16-19. doi:10.14227/DT240217P16

    • NLM

      Bachour G, Bou-Chacra NA, Löbenberg R. Evaluation of the rupture test for stability studies of soft-shell capsules [Internet]. Dissolution Technologies. 2017 ; 24( 2): 16-19.[citado 2024 maio 02 ] Available from: https://doi.org/10.14227/DT240217P16

    • Vancouver

      Bachour G, Bou-Chacra NA, Löbenberg R. Evaluation of the rupture test for stability studies of soft-shell capsules [Internet]. Dissolution Technologies. 2017 ; 24( 2): 16-19.[citado 2024 maio 02 ] Available from: https://doi.org/10.14227/DT240217P16

  • Artigo de periodico

    Evaluation of the DDSolver software applications (2014)

    Zuo, Jieyu; Gao, Yuan; Bou-Chacra, Nadia Araci ; Löbenberg, Raimar

    Source: BioMed Research International. Unidade: FCF

    Subjects: SOFTWARES, FARMACOCINÉTICA, FÁRMACOS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      ZUO, Jieyu et al. Evaluation of the DDSolver software applications. BioMed Research International, p. 1-9 art. 204925, 2014Tradução . . Disponível em: https://doi.org/10.1155/2014/204925. Acesso em: 02 maio 2024.

    • APA

      Zuo, J., Gao, Y., Bou-Chacra, N. A., & Löbenberg, R. (2014). Evaluation of the DDSolver software applications. BioMed Research International, 1-9 art. 204925. doi:10.1155/2014/204925

    • NLM

      Zuo J, Gao Y, Bou-Chacra NA, Löbenberg R. Evaluation of the DDSolver software applications [Internet]. BioMed Research International. 2014 ; 1-9 art. 204925.[citado 2024 maio 02 ] Available from: https://doi.org/10.1155/2014/204925

    • Vancouver

      Zuo J, Gao Y, Bou-Chacra NA, Löbenberg R. Evaluation of the DDSolver software applications [Internet]. BioMed Research International. 2014 ; 1-9 art. 204925.[citado 2024 maio 02 ] Available from: https://doi.org/10.1155/2014/204925

  • Artigo de periodico

    Development of a novel in vitro model to study lymphatic uptake of drugs via artificial chylomicrons (2023)

    Yousef, Malaz ; Park, Chulhun ; Henostroza, Mirla ; Bou-Chacra, Nadia Araci ; Davies, Neal M ; Löbenberg, Raimar

    Source: Pharmaceutics. Unidade: FCF

    Subjects: SISTEMA LINFÁTICO, MEDICAMENTO

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      YOUSEF, Malaz et al. Development of a novel in vitro model to study lymphatic uptake of drugs via artificial chylomicrons. Pharmaceutics, v. 2, p. 1-17 art. 2532, 2023Tradução . . Disponível em: https://dx.doi.org/10.3390/pharmaceutics15112532. Acesso em: 02 maio 2024.

    • APA

      Yousef, M., Park, C., Henostroza, M., Bou-Chacra, N. A., Davies, N. M., & Löbenberg, R. (2023). Development of a novel in vitro model to study lymphatic uptake of drugs via artificial chylomicrons. Pharmaceutics, 2, 1-17 art. 2532. doi:10.3390/pharmaceutics15112532

    • NLM

      Yousef M, Park C, Henostroza M, Bou-Chacra NA, Davies NM, Löbenberg R. Development of a novel in vitro model to study lymphatic uptake of drugs via artificial chylomicrons [Internet]. Pharmaceutics. 2023 ; 2 1-17 art. 2532.[citado 2024 maio 02 ] Available from: https://dx.doi.org/10.3390/pharmaceutics15112532

    • Vancouver

      Yousef M, Park C, Henostroza M, Bou-Chacra NA, Davies NM, Löbenberg R. Development of a novel in vitro model to study lymphatic uptake of drugs via artificial chylomicrons [Internet]. Pharmaceutics. 2023 ; 2 1-17 art. 2532.[citado 2024 maio 02 ] Available from: https://dx.doi.org/10.3390/pharmaceutics15112532

  • Artigo de periodico

    Design space approach for preservative system optimization of an anti-aging eye fluid emulsion (2015)

    Lourenço, Felipe Rebello ; Francisco, Fabiane Lacerda; Ferreira, Márcia Regina Spuri; Pinto, Terezinha de Jesus Andreoli ; Löbenberg, Raimar; Bou-Chacra, Nadia Araci

    Source: Journal of Pharmacy Pharmaceutical Sciences. Unidade: FCF

    Subjects: EMULSÕES COSMÉTICAS, CONSERVANTES

    Acesso à fonteAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      LOURENÇO, Felipe Rebello et al. Design space approach for preservative system optimization of an anti-aging eye fluid emulsion. Journal of Pharmacy Pharmaceutical Sciences, v. 18, n. 3, p. 551-561, 2015Tradução . . Disponível em: https://doi.org/10.18433/J3J600. Acesso em: 02 maio 2024.

    • APA

      Lourenço, F. R., Francisco, F. L., Ferreira, M. R. S., Pinto, T. de J. A., Löbenberg, R., & Bou-Chacra, N. A. (2015). Design space approach for preservative system optimization of an anti-aging eye fluid emulsion. Journal of Pharmacy Pharmaceutical Sciences, 18( 3), 551-561. doi:10.18433/J3J600

    • NLM

      Lourenço FR, Francisco FL, Ferreira MRS, Pinto T de JA, Löbenberg R, Bou-Chacra NA. Design space approach for preservative system optimization of an anti-aging eye fluid emulsion [Internet]. Journal of Pharmacy Pharmaceutical Sciences. 2015 ; 18( 3): 551-561.[citado 2024 maio 02 ] Available from: https://doi.org/10.18433/J3J600

    • Vancouver

      Lourenço FR, Francisco FL, Ferreira MRS, Pinto T de JA, Löbenberg R, Bou-Chacra NA. Design space approach for preservative system optimization of an anti-aging eye fluid emulsion [Internet]. Journal of Pharmacy Pharmaceutical Sciences. 2015 ; 18( 3): 551-561.[citado 2024 maio 02 ] Available from: https://doi.org/10.18433/J3J600

  • Artigo de periodico

    Co-delivery of buparvaquone and polymyxin B in a nanostructured lipid carrier for leishmaniasis treatment (2019)

    Monteiro, Lis Marie ; Löbenberg, Raimar ; Fotaki, Nikoletta; Araujo, Gabriel Lima Barros de ; Cotrim, Paulo César ; Bou-Chacra, Nadia Araci

    Source: Journal of Global Antimicrobial Resistance. Unidades: FCF, FM

    Subjects: QUITOSANA, LEISHMANIA, NANOTECNOLOGIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      MONTEIRO, Lis Marie et al. Co-delivery of buparvaquone and polymyxin B in a nanostructured lipid carrier for leishmaniasis treatment. Journal of Global Antimicrobial Resistance, v. 18, p. 279-283, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.jgar.2019.06.006. Acesso em: 02 maio 2024.

    • APA

      Monteiro, L. M., Löbenberg, R., Fotaki, N., Araujo, G. L. B. de, Cotrim, P. C., & Bou-Chacra, N. A. (2019). Co-delivery of buparvaquone and polymyxin B in a nanostructured lipid carrier for leishmaniasis treatment. Journal of Global Antimicrobial Resistance, 18, 279-283. doi:10.1016/j.jgar.2019.06.006

    • NLM

      Monteiro LM, Löbenberg R, Fotaki N, Araujo GLB de, Cotrim PC, Bou-Chacra NA. Co-delivery of buparvaquone and polymyxin B in a nanostructured lipid carrier for leishmaniasis treatment [Internet]. Journal of Global Antimicrobial Resistance. 2019 ; 18 279-283.[citado 2024 maio 02 ] Available from: https://doi.org/10.1016/j.jgar.2019.06.006

    • Vancouver

      Monteiro LM, Löbenberg R, Fotaki N, Araujo GLB de, Cotrim PC, Bou-Chacra NA. Co-delivery of buparvaquone and polymyxin B in a nanostructured lipid carrier for leishmaniasis treatment [Internet]. Journal of Global Antimicrobial Resistance. 2019 ; 18 279-283.[citado 2024 maio 02 ] Available from: https://doi.org/10.1016/j.jgar.2019.06.006

1 - 20 (23 records)

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024